Ms Jenelle Vella-burton, OTR/L | |
Psc 819 Box 18, Fpo, AE 09645-0001 | |
(011) 349-56823524 | |
Not Available |
Full Name | Ms Jenelle Vella-burton |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | Psc 819 Box 18, Fpo, Armed Forces Europe |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538582176 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 5093 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Jenelle Vella-burton, OTR/L Psc 819 Box 18, Fpo, AE 09645-0001 Ph: (011) 349-56823524 | Ms Jenelle Vella-burton, OTR/L Psc 819 Box 18, Fpo, AE 09645-0001 Ph: (011) 349-56823524 |
News Archive
The recall notice was issued Tuesday by the U.S. Department of Agriculture and affects about 10,260 pounds of frozen spaghetti and meatballs. Food maker Nestle, in its statement, says the affected packages were produced in October. The health risk associated with this recall is low, the USDA's Food Safety and Inspection Service explained. If the product is consumed, there is only a remote probability of adverse health consequences.
Researchers at the Sahlgrenska Academy in Gothenburg show for the first time that exercise helps restore stem cell growth and improves behavior in young mice that suffered damage to the brain induced by a clinically relevant dose of radiation. The researchers believe that these results are also applicable to children that have suffered damage due to radiotherapy of brain tumors.
Inhibitex, Inc., today announced its financial results for the third quarter ended September 30, 2009. The Company held cash, cash equivalents and short-term investments of $21.1 million at September 30, 2009, as compared to $33.1 million at December 31, 2008.
Apitope, the European drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announced completion of recruitment into its second Phase I clinical trial of ATX-MS-1467 in patients with multiple sclerosis (MS).
› Verified 3 days ago
Mackenzie R Day, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Psc 819 Box 18, Fpo, AE 09645 Phone: 314-727-3305 |